Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 47, 4407-4412, August 15, 1987]
© 1987 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nutter, L. M.
Right arrow Articles by Cheng, Y.-c.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nutter, L. M.
Right arrow Articles by Cheng, Y.-c.

Induction of Virus Enzymes by Phorbol Esters and n-Butyrate in Epstein-Barr Virus Genome-carrying Raji Cells1

Louise M. Nutter2, Susan P. Grill, Jin-sen Li, Rung-sen Tan3 and Yung-chi Cheng4

Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27514

Phorbol esters and n-butyrate (SB) together could induce Epstein-Barr virus (EBV) DNA polymerase and DNase activities in Raji cells (virus nonproducer). Neither 12-O-tetradecanoylphorbol-13-acetate (TPA) nor SB alone could induce these EBV enzyme activities, transcription of the EcoRI C-region or other EBV proteins in Raji cells. The enzyme induction caused by exposure of Raji cells to TPA-SB was the result of the synthesis of virus-specified RNA, and the increase of linear EBV DNA content in Raji cells caused by TPA alone was not sufficient for induction of EBV-enzyme activities. Temporal characteristics of the TPA-SB induction process, but not the phorbol 12,13-dibutyrate-SB induction process, in Raji cells were observed; a critical phase (10–24 h) postphorbol ester treatment in phorbol 12,13-dibutyrate-SB-treated Raji cells which was responsible for the synthesis of virus RNA and enzymes was found. Phospholipase C, which increases intracellular diacylglycerols (and subsequently activates protein kinase C) was able to partially substitute for TPA in the TPA-SB induction for EBV polymerase and DNase activities. Sphingosine, a protein kinase C inhibitor, partially prevented the induction of virus enzyme activities in Raji cells treated with phorbol 12,13-dibutyrate and SB. No apparent changes in the methylation state of EBV DNA (EcoRI C region) were observed when Raji cells were treated with SB and TPA, alone or in combination. These results suggest that induction of EBV polymerase and DNase activities by TPA-SB may involve protein kinase C activation and another factor triggered by SB which together increase transcription of EBV DNA.

1 Supported by NIH Grant CA443580.

2 Present address: Institute of Biomedical Science, Academia Sinica, Taipei, China.

3 Present address: Department of Biochemistry, Cancer Institute, Chinese Academy of Science, Beijing, China.

4 To whom requests for reprints should be addressed.

Received 12/10/86. Revised 5/15/87. Accepted 5/21/87.




This article has been cited by other articles:


Home page
J. Virol.Home page
P. Wang, L. Day, J. Dheekollu, and P. M. Lieberman
A Redox-Sensitive Cysteine in Zta Is Required for Epstein-Barr Virus Lytic Cycle DNA Replication
J. Virol., November 1, 2005; 79(21): 13298 - 13309.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
L.-K. Chang and S.-T. Liu
Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation
Nucleic Acids Res., October 15, 2000; 28(20): 3918 - 3925.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y.-L. Chung, Y.-H. W. Lee, S.-H. Yen, and K.-H. Chi
A Novel Approach for Nasopharyngeal Carcinoma Treatment Uses Phenylbutyrate as a Protein Kinase C Modulator: Implications for Radiosensitization and EBV-targeted Therapy
Clin. Cancer Res., April 1, 2000; 6(4): 1452 - 1458.
[Abstract] [Full Text]


Home page
CVIHome page
H. B. Jenson, G. M. Grant, Y. Ench, P. Heard, C. A. Thomas, S. G. Hilsenbeck, and M. P. Moyer
Immunofluorescence Microscopy and Flow Cytometry Characterization of Chemical Induction of Latent Epstein-Barr Virus
Clin. Vaccine Immunol., January 1, 1998; 5(1): 91 - 97.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Y. Y. K. H. and Genji Imokawa and Y. Yada
Purification and Biochemical Characterization of Membrane-bound Epidermal Ceramidases from Guinea Pig Skin
J. Biol. Chem., May 26, 1995; 270(21): 12677 - 12684.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1987 by the American Association for Cancer Research.